Structural analysis between arsenic and CYP2C8 enzyme interaction by docking

被引：0
|
作者：
Rangel Lopez, A. [1 ,2 ]
Nieto Delgado, G. [2 ]
Vertiz Hernandez, A. [1 ,2 ]
Terrones Gurrola, R. [1 ,2 ]
机构：
[1] Univ Autonoma San Luis Potosi, Matehuala, Mexico
[2] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [41] Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively
    Wen, X
    Wang, JS
    Backman, JT
    Laitila, J
    Neuvonen, PJ
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) : 631 - 635
  • [42] CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
    Johansson, Maria
    Strahm, Emmanuel
    Rane, Anders
    Ekstrom, Lena
    FRONTIERS IN GENETICS, 2014, 5
  • [43] Assessment of Some Pesticides Interactions with Human Cytochrome P450: CYP2C8, CYP2C9 and CYP2C19 by Molecular Docking Approach
    Ciorsac, Alecu
    Vladoiu, Diana Larisa
    Fagnen, Charline
    Louet, Maxime
    Miteva, Maria A.
    Isvoran, Adriana
    9TH INTERNATIONAL PHYSICS CONFERENCE OF THE BALKAN PHYSICAL UNION (BPU-9), 2016, 1722
  • [44] Recovery of CYP2C8 Activity after Gemfibrozil Administration: Estimation of CYP2C8 Half-Life using Repaglinide as an In Vivo Probe
    Honkalammi, Johanna
    Backman, Janne T.
    Niemi, Mikko
    Tornio, Aleksi
    Neuvonen, Pertti J.
    DRUG METABOLISM REVIEWS, 2009, 41 : 49 - 49
  • [45] CYP2C8 genotyping in malaria patients of the Zanzibar islands
    Cavaco, I
    Gil, P
    Ribeiro, V
    Björkman, A
    DRUG METABOLISM REVIEWS, 2003, 35 : 135 - 135
  • [46] Relationship between CYP2C8 and CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.
    Dorado, P.
    Cavaco, I
    Caceres, M. C.
    Píedade, R.
    Ribeiro, V
    LLerena, A.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 229 - 229
  • [47] The role of CYP2C8 and CYP2C9 genotypes in acute myocardial infarction
    Yasar, Ü
    Bennet, A
    Eliasson, E
    Lundgren, S
    Wiman, B
    de Faire, U
    Rane, A
    DRUG METABOLISM REVIEWS, 2003, 35 : 132 - 132
  • [48] Evaluation of the Relationship between Sex, Polymorphisms in CYP2C8 and CYP2C9, and Pharmacokinetics of Angiotensin Receptor Blockers
    Cabaleiro, Teresa
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Prieto-Perez, Rocio
    Wojnicz, Aneta
    Lopez-Rodriguez, Rosario
    Novalbos, Jesus
    Abad-Santos, Francisco
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 224 - 229
  • [49] Pharmacokinetics and pharmacodynamics of rosiglitazone in elation to CYP2C8 genotype
    Kirchheiner, Julia
    Thomas, Soju
    Bauer, Steffen
    Tomalik-Scharte, Dorota
    Hering, Ursula
    Doroshyenko, Oxana
    Jetter, Alexander
    Stehle, Simone
    Tsahuridu, Martina
    Meineke, Ingolf
    Brockmoeller, Juergen
    Fuhr, Uwe
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (06) : 657 - 667
  • [50] Effect of CYP2C8 genotype on rosiglitazone pharmacokinetics.
    Hruska, MW
    Cheong, JA
    Amico, JA
    Langaee, TY
    Frye, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P36 - P36
12345